Search results
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive· 2 days agoSales data suggest forecasts for the Alzheimer’s drug may be in reach. Elsewhere, Ipsen is licensing...
Flagship raises $3.6B for biotech investing
BioPharma Dive· 4 days agoThe company’s in-house drug development unit, Pioneering Medicines, now includes more than 100 employees with a pipeline of 10 experimental therapies....
Top Gainers and Losers today on 10 July, 2024: Asian Paints, SBI Life Insurance Company, Mahindra &...
Livemint· 4 days agoTop Gainers and Losers Today : The Sensex lost 426.87 points, or -0.53, to settle at 80351.64, while...
NICE recommends Ebglyss for atopic dermatitis patients
Pharmaceutical Technology· 4 days agoThe Janus kinase (JAK) inhibitors Cibinqo (abrocitinib), Olumiant (baricitinib), and Rinvoq...
S&P 500 declines, Nasdaq falls 2% in a rare event on Wall Street after 45 years - CNBC TV18
CNBC TV18· 2 days agoThe US markets had a mixed day on Thursday as benchmark indices saw sharp cuts but the broader...
‘India has a High Appetite for Generative AI,’ says AWS's Chief Medical Officer
Analytics India Magazine· 5 days agoAt the AWS Summit, Washington DC, Rowland Illing, the director and chief medical officer for global healthcare and non-profits, AWS, acknowledged the same. The technology can help with language ...
HSBC Flexi Cap review: 22% returns in three years; should you invest in this flexi-cap fund?
The Economic Times· 6 days agoEarlier known as HSBC Multicap Equity, this fund was rebranded to reflect its fluid positioning as a...
Lilly to buy Morphic in $3B bet on inflammation drug
BioPharma Dive· 6 days agoThe deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel...
Torrent Pharma. Summary: Latest Updates and Details | India Infoline
India Infoline· 5 days agoTorrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets. The Company is a dominant ...
Will small and midcap rallies continue and have more momentum vs largecaps? Vinit Sambre explains
The Economic Times· 6 days agoVinit Sambre, Head-Equities, DSP Mutual Fund, says growth and visibility and anticipation of growth...
